Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ring finger protein 1 (RING1), also known as E3 ubiquitin-protein ligase RING1, is an enzyme in humans encoded by the RING1 gene. It is a member of the RING finger family, characterized by a RING domain—a zinc-coordinating motif—critical for its function as an E3 ubiquitin ligase. RING1 is a core enzymatic component of the Polycomb repressive complex 1 (PRC1), mediating monoubiquitination of histone H2A at lysine 119, thereby contributing to transcriptional repression and chromatin compaction. Through its association with PRC1, RING1 plays key roles in epigenetic regulation during development, stem cell maintenance, and cell fate determination. Mutations or dysregulation of RING1 have been implicated in developmental disorders and cancers, highlighting its central role in gene silencing and epigenetic control[2][3][4][5].
Inhibition of E3 ubiquitin ligase activity (theoretical/experimental, targeted for modulating chromatin state); Disruption of PRC1 complex function (theoretical target for epigenetic therapies)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ring finger protein 1 (RING1).